Literature DB >> 20933122

New frontiers in nonhormonal male contraception.

C Yan Cheng1, Dolores D Mruk.   

Abstract

The world's population is nearing 6.8 billion, and we are in need of a male contraceptive that is safe, effective, reversible and affordable. Hormonal approaches, which employ different formulations of testosterone administered in combination with other hormones, have shown considerable promise in clinical trials, and they are currently at the forefront of research and development. However, the long-term effects of using hormones throughout a male's reproductive life for contraception are unknown, and it may take decades before this information becomes available. Because of this, many investigators are aiming to bring a nonhormonal male contraceptive to the consumer market. Indeed, there are several distinct but feasible avenues in which fertility can be regulated without affecting the hypothalamus-pituitary-testis axis. In this review, we discuss several approaches for fertility control involving the testis that one day may lead to the development of a nonhormonal male contraceptive.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20933122      PMCID: PMC4381878          DOI: 10.1016/j.contraception.2010.03.017

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  81 in total

Review 1.  T-type Ca2+ channels in sperm function.

Authors:  Alberto Darszon; Pablo López-Martínez; Juan José Acevedo; Arturo Hernández-Cruz; Claudia L Treviño
Journal:  Cell Calcium       Date:  2006-06-23       Impact factor: 6.817

2.  Ultrastructural changes in the spermatozoa of langur monkeys Presbytis entellus entellus after vas occlusion with styrene maleic anhydride.

Authors:  N K Lohiya; B Manivannan; P K Mishra
Journal:  Contraception       Date:  1998-02       Impact factor: 3.375

3.  Adjudin targeting rabbit germ cell adhesion as a male contraceptive: a pharmacokinetics study.

Authors:  Guo-Xin Hu; Lu-Feng Hu; Dai-Zheng Yang; Jun-Wei Li; Guo-Rong Chen; Bing-Bing Chen; Dolores D Mruk; Michele Bonanomi; Bruno Silvestrini; C Yan Cheng; Ren-Shan Ge
Journal:  J Androl       Date:  2008-09-18

4.  Effects of AF 1312 TS and lonidamine on mammalian testis. A morphological study.

Authors:  C De Martino; W Malcorni; M Bellocci; A Floridi; M L Marcante
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

5.  Effects of CDB-4022 on Leydig cell function in adult male rats.

Authors:  Yu-Chyu Chen; Renate K Cochrum; Michael T Tseng; Dushan T Ghooray; Joseph P Moore; Stephen J Winters; Barbara J Clark
Journal:  Biol Reprod       Date:  2007-08-22       Impact factor: 4.285

6.  Immune-related disease before and after vasectomy: an epidemiological database study.

Authors:  M J Goldacre; C J Wotton; V Seagroatt; D Yeates
Journal:  Hum Reprod       Date:  2007-02-06       Impact factor: 6.918

Review 7.  Eppin: an epididymal protease inhibitor and a target for male contraception.

Authors:  M G O'Rand; E E Widgren; Zengjun Wang; R T Richardson
Journal:  Soc Reprod Fertil Suppl       Date:  2007

Review 8.  Development of genetically engineered human sperm immunocontraceptives.

Authors:  Rajesh K Naz
Journal:  J Reprod Immunol       Date:  2009-10-23       Impact factor: 4.054

9.  Vasectomy and health. Results from a large cohort study.

Authors:  F J Massey; G S Bernstein; W M O'Fallon; L M Schuman; A H Coulson; R Crozier; J S Mandel; R B Benjamin; H W Berendes; P C Chang
Journal:  JAMA       Date:  1984 Aug 24-31       Impact factor: 56.272

10.  Sperm characteristics and teratology in rats following vas deferens occlusion with RISUG and its reversal.

Authors:  N K Lohiya; R Suthar; A Khandelwal; S Goyal; A S Ansari; B Manivannan
Journal:  Int J Androl       Date:  2009-10-06
View more
  20 in total

1.  Testin and actin are key molecular targets of adjudin, an anti-spermatogenic agent, in the testis.

Authors:  Dolores D Mruk; C Yan Cheng
Journal:  Spermatogenesis       Date:  2011-04

Review 2.  Effective Delivery of Male Contraceptives Behind the Blood-Testis Barrier (BTB) - Lesson from Adjudin.

Authors:  Haiqi Chen; Dolores D Mruk; Weiliang Xia; Michele Bonanomi; Bruno Silvestrini; Chuen-Yan Cheng
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

3.  Interactions of laminin β3 fragment with β1-integrin receptor: A revisit of the apical ectoplasmic specialization-blood-testis-barrier-hemidesmosome functional axis in the testis.

Authors:  C Yan Cheng; Pearl Py Lie; Ka-Wai Mok; Yan-Ho Cheng; Elissa Wp Wong; Jayakanthan Mannu; Premendu P Mathur; Helen H N Yan; Dolores D Mruk
Journal:  Spermatogenesis       Date:  2011-07-01

4.  A study to assess the assembly of a functional blood-testis barrier in developing rat testes.

Authors:  Ka-Wai Mok; Dolores D Mruk; Will M Lee; C Yan Cheng
Journal:  Spermatogenesis       Date:  2011-07-01

5.  Actin-binding protein drebrin E is involved in junction dynamics during spermatogenesis.

Authors:  Michelle Wm Li; Xiang Xiao; Dolores D Mruk; Yee-Ling Lam; Will M Lee; Wing-Yee Lui; Michele Bonanomi; Bruno Silvestrini; C Yan Cheng
Journal:  Spermatogenesis       Date:  2011 Apr-Jun

Review 6.  Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis.

Authors:  Yan-Ho Cheng; Elissa Wp Wong; C Yan Cheng
Journal:  Spermatogenesis       Date:  2011-07-01

Review 7.  Interaction of oligomeric breast cancer resistant protein (BCRP) with adjudin: a male contraceptive with anti-cancer activity.

Authors:  Yan Ho Cheng; Pranitha Jenardhanan; Premendu P Mathur; Xiaojing Qian; Weiliang Xia; Bruno Silvestrini; Chuen Yan Cheng
Journal:  Curr Mol Pharmacol       Date:  2014       Impact factor: 3.339

Review 8.  The blood-testis barrier and its implications for male contraception.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Pharmacol Rev       Date:  2011-10-28       Impact factor: 25.468

Review 9.  Drug transporters, the blood-testis barrier, and spermatogenesis.

Authors:  Linlin Su; Dolores D Mruk; C Yan Cheng
Journal:  J Endocrinol       Date:  2010-12-06       Impact factor: 4.286

10.  Contraceptive methods: needs, options and utilization.

Authors:  Rakhi Jain; Sumathi Muralidhar
Journal:  J Obstet Gynaecol India       Date:  2012-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.